详细信息

促渗剂对淫羊藿苷体外经皮渗透特性影响的研究     被引量:6

Effect of penetration enhancers on percutaneous penetration characteristics of icariin in vitro

文献类型:期刊文献

中文题名:促渗剂对淫羊藿苷体外经皮渗透特性影响的研究

英文题名:Effect of penetration enhancers on percutaneous penetration characteristics of icariin in vitro

作者:何红杰[1];王继龙[1];刘晓霞[1];冉鑫[1];魏舒畅[2];冯晓莉[1];万玲娟[1]

第一作者:何红杰

机构:[1]甘肃中医药大学,甘肃兰州730000;[2]甘肃省中药制药工艺工程研究中心,甘肃兰州730000

第一机构:甘肃中医药大学

年份:2021

卷号:32

期号:11

起止页码:2661

中文期刊名:时珍国医国药

外文期刊名:Lishizhen Medicine and Materia Medica Research

收录:北大核心:【北大核心2020】;CSCD:【CSCD_E2021_2022】;

基金:国家自然科学基金(82060721);敦煌医学与转化教育部重点实验室项目(DHYX20-12)。

语种:中文

中文关键词:经皮渗透;促渗剂;正交设计;淫羊藿

外文关键词:Percutaneous penetration;Penetration promoter;Orthogonal design;Epimedium;Icariin

摘要:目的研究不同透皮促渗剂对淫羊藿苷体外经皮渗透的影响,筛选出最佳促渗剂。方法选用氮酮、薄荷脑、冰片为促渗剂,采用Franz扩散池法,考察单一促渗剂及三元复合促渗剂对淫羊藿苷体外透皮吸收的影响,采用正交设计,选用L_(9)(3^(4))正交试验表,以淫羊藿苷累积渗透量为指标,优选出三元复合促渗剂。以雄性小鼠离体皮肤作为渗透屏障,含20%乙醇的PBS溶液为接收液,HPLC法测定淫羊藿苷的含量。结果促渗剂以1%氮酮、2%冰片及2%薄荷脑为组合时促渗效果最佳。结论三元复合促渗剂可显著提高淫羊藿苷的经皮渗透性,为后续将淫羊藿及以淫羊藿为主要的方剂制备成经皮制剂提供促渗物质。
Objective To study the effects of different transdermal enhancers on the percutaneous penetration of icariin in vitro, and select the best enhancer. Methods Azone, menthol and borneol were selected as penetration enhancers. Franz diffusion cell method was used to investigate the effects of single penetration enhancer and ternary composite penetration enhancer on the percutaneous absorption of icariin in vitro. Orthogonal design was adopted, L_(9)(3^(4)) orthogonal test table was selected, and the cumulative penetration amount of icariin was taken as the index to screen out the best ternary penetration enhancer. The content of icariin was determined by HPLC with the isolated skin of male mice as permeation barrier and PBS solution containing 20% ethanol as receiving solution. Results The combination of 1% azone, 2% borneol and 2% menthol had the best permeation promoting effect. Conclusion Ternary penetration enhancers could significantly improve the transdermal permeability of icariin, and provide penetration enhancers for the subsequent preparation of epimedium and epimedium-containing prescriptions into transdermal preparations.

参考文献:

正在载入数据...

版权所有©甘肃中医药大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心